A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Original Article

M.D. Cappellini, V. Viprakasit, A.T. Taher, P. Georgiev, K.H. Kuo, T. Coates, E. Voskaridou, H.-K. Liew, I. Pazgal-Kobrowski, G. Forni, S. Perrotta, A. Khelif, A. Lal, A. Kattamis, E. Vlachaki, R. Origa, Y. Aydinok, M. Bejaoui, P.J. Ho, L.-P. Chew, P.-C. Bee, S.-M. Lim, M.-Y. Lu, A. Tantiworawit, P. Ganeva, L. Gercheva, F. Shah, E.J. Neufeld, A. Thompson, A. Laadem, J.K. Shetty, J. Zou, J. Zhang, D. Miteva, T. Zinger, P.G. Linde, M.L. Sherman, O. Hermine, J. Porter, and A. Piga

N Engl J Med 2020;382:1219-1231

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
03/25/2020
Course expires: 
03/26/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, March 26, 2022 - 11:59pm.